SciSight Ecosystem
WoS SCIE Q1Hybrid

Journal of Oncology

Abbreviation (ISO):J ONCOL
Country: United States•WoS SCIE Quartile: Q1•Identifier (ISSN):1687-8450(Print)/1687-8469(Online)•Articles / Year: 344
Clarivate JCR Index Advisory: Dropped from SCI (2023-03-20)
Clarivate Impact Factor (IF 2024)Q1
N/A

Leading citation impact metric from Clarivate Journal Citation Reports

H-Index (2021)
47

47 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
344articles/year
99.23% Gold OA•90.7% Original Research

Aims & Scope

Journal of Oncology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to breast cancer, lung cancer, gastrointestinal cancer, skin cancer, head and neck cancer, paediatric oncology, neurooncology as well as genitourinary cancer. The journal provides a multidisciplinary forum for translational and clinical oncology research in the areas of molecular pathology, genomics, diagnosis and therapy, with a specific focus on molecular targeted agents and novel immune therapies.

Topics Covered (Recognized by AI)
Medicine99.6%Biology94.2%Internal medicine93.9%Genetics88.8%Cancer68%Pathology54.5%Chemistry53%Oncology51.6%Biochemistry48.9%Surgery47.1%Cancer research42.2%Gene34.6%Immunology32.8%Mathematics26%Radiology25.7%Statistics20.1%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Hindawi Publishing Corporation
Publication Language
English
Frequency
Periodic
Editorial Address
ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, ENGLAND, W1T 5HF
Indexing & Databases
SCIEScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—130
2025—160
2024—23
20230166836
20224.5019669,218
20214.3754426,408
20202.2062184,671
20192.62468,970
20184.528521,249
2017—13688
2016—19746
2015—361,856
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Journal of Oncology

WoS Q1
02462018201920202021202220230.00
Annual Impact Factor Metric
2023:0

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: a2d34bb6-1b6b-4d68-b01f-1d568ff8eb1e
Database Updated: 2026-09-30